134 related articles for article (PubMed ID: 31823876)
21. Stress, depression, and neuroplasticity: a convergence of mechanisms.
Pittenger C; Duman RS
Neuropsychopharmacology; 2008 Jan; 33(1):88-109. PubMed ID: 17851537
[TBL] [Abstract][Full Text] [Related]
22. Assessment of neuroplasticity in late-life depression with transcranial magnetic stimulation.
Bhandari A; Lissemore JI; Rajji TK; Mulsant BH; Cash RFH; Noda Y; Zomorrodi R; Karp JF; Lenze EJ; Reynolds CF; Daskalakis ZJ; Blumberger DM
J Psychiatr Res; 2018 Oct; 105():63-70. PubMed ID: 30195122
[TBL] [Abstract][Full Text] [Related]
23. Treatment-resistant bipolar depression: a randomized controlled trial of electroconvulsive therapy versus algorithm-based pharmacological treatment.
Schoeyen HK; Kessler U; Andreassen OA; Auestad BH; Bergsholm P; Malt UF; Morken G; Oedegaard KJ; Vaaler A
Am J Psychiatry; 2015 Jan; 172(1):41-51. PubMed ID: 25219389
[TBL] [Abstract][Full Text] [Related]
24. Exercise-Induced Neuroprotection and Recovery of Motor Function in Animal Models of Parkinson's Disease.
Palasz E; Niewiadomski W; Gasiorowska A; Wysocka A; Stepniewska A; Niewiadomska G
Front Neurol; 2019; 10():1143. PubMed ID: 31736859
[TBL] [Abstract][Full Text] [Related]
25. [Neuroplasticity and Parkinson disease].
Viallet F; Witjas T
Rev Neurol (Paris); 2002 Dec; 158 Spec no 1():S42-8. PubMed ID: 12690663
[TBL] [Abstract][Full Text] [Related]
26. [Interaction of 5-HT and HPA axis in depression and treatment-resistant depression].
Kitamura Y; Araki H; Gomita Y
Nihon Yakurigaku Zasshi; 2002 Jun; 119(6):319-25. PubMed ID: 12089903
[TBL] [Abstract][Full Text] [Related]
27. Adult hippocampal neuroplasticity triggers susceptibility to recurrent depression.
Alves ND; Correia JS; Patrício P; Mateus-Pinheiro A; Machado-Santos AR; Loureiro-Campos E; Morais M; Bessa JM; Sousa N; Pinto L
Transl Psychiatry; 2017 Mar; 7(3):e1058. PubMed ID: 28291258
[TBL] [Abstract][Full Text] [Related]
28. [Pharmacotherapy of depression: recent developments].
Baumann P
Rev Med Suisse; 2007 Sep; 3(125):2079-80, 2083-4. PubMed ID: 17939526
[TBL] [Abstract][Full Text] [Related]
29. Neuroplasticity-related mechanisms underlying the antidepressant-like effects of traditional herbal medicines.
Hirshler Y; Doron R
Eur Neuropsychopharmacol; 2017 Oct; 27(10):945-958. PubMed ID: 28807619
[TBL] [Abstract][Full Text] [Related]
30. Dopaminergic agents in the treatment of bipolar depression: a systematic review and meta-analysis.
Szmulewicz AG; Angriman F; Samamé C; Ferraris A; Vigo D; Strejilevich SA
Acta Psychiatr Scand; 2017 Jun; 135(6):527-538. PubMed ID: 28256707
[TBL] [Abstract][Full Text] [Related]
31. Physical exercise ameliorates psychiatric disorders and cognitive dysfunctions by hippocampal mitochondrial function and neuroplasticity in post-traumatic stress disorder.
Seo JH; Park HS; Park SS; Kim CJ; Kim DH; Kim TW
Exp Neurol; 2019 Dec; 322():113043. PubMed ID: 31446079
[TBL] [Abstract][Full Text] [Related]
32. Cell signalling in CNS and immune system in depression and during antidepressant treatment: focus on glial and natural killer cells.
Kovaru H; Pav M; Kovaru F; Raboch J; Fiserova A
Neuro Endocrinol Lett; 2009; 30(4):421-8. PubMed ID: 20010506
[TBL] [Abstract][Full Text] [Related]
33. Potentiation strategies for treatment-resistant depression.
Ros S; Agüera L; de la Gándara J; Rojo JE; de Pedro JM
Acta Psychiatr Scand Suppl; 2005; (428):14-24, 36. PubMed ID: 16307616
[TBL] [Abstract][Full Text] [Related]
34. Neuroplastic changes in depression: a role for the immune system.
Eyre H; Baune BT
Psychoneuroendocrinology; 2012 Sep; 37(9):1397-416. PubMed ID: 22525700
[TBL] [Abstract][Full Text] [Related]
35. The modulation of adult neuroplasticity is involved in the mood-improving actions of atypical antipsychotics in an animal model of depression.
Morais M; Patrício P; Mateus-Pinheiro A; Alves ND; Machado-Santos AR; Correia JS; Pereira J; Pinto L; Sousa N; Bessa JM
Transl Psychiatry; 2017 Jun; 7(6):e1146. PubMed ID: 28585931
[TBL] [Abstract][Full Text] [Related]
36. Pharmacological Enhancement of Stroke Recovery.
Kumar A; Kitago T
Curr Neurol Neurosci Rep; 2019 May; 19(7):43. PubMed ID: 31144053
[TBL] [Abstract][Full Text] [Related]
37. [Neuroplasticity and Parkinson's disease].
Viallet F; Witjas T
Rev Neurol (Paris); 2002; 158(122):42-48. PubMed ID: 12690314
[TBL] [Abstract][Full Text] [Related]
38. MPTP Mouse Model of Preclinical and Clinical Parkinson's Disease as an Instrument for Translational Medicine.
Mingazov ER; Khakimova GR; Kozina EA; Medvedev AE; Buneeva OA; Bazyan AS; Ugrumov MV
Mol Neurobiol; 2018 Apr; 55(4):2991-3006. PubMed ID: 28456940
[TBL] [Abstract][Full Text] [Related]
39. The brain dopaminergic system. Pharmacological, behavioural and electrophysiological studies.
Glenthøj BY
Dan Med Bull; 1995 Feb; 42(1):1-21. PubMed ID: 7729164
[TBL] [Abstract][Full Text] [Related]
40. Executive Dysfunction Predicts Treatment Response to Neuroplasticity-Based Computerized Cognitive Remediation (nCCR-GD) in Elderly Patients with Major Depression.
Morimoto SS; Gunning FM; Wexler BE; Hu W; Ilieva I; Liu J; Nitis J; Alexopoulos GS
Am J Geriatr Psychiatry; 2016 Oct; 24(10):816-20. PubMed ID: 27591163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
